Legacy Effect of Delayed Blood Pressure-Lowering Pharmacotherapy in Middle-Aged Individuals Stratified by Absolute Cardiovascular Disease Risk: Protocol for a Systematic Review.
Background: Many national and international guidelines recommend that the initiation of blood pressure (BP)-lowering drug treatment for the primary prevention of cardiovascular disease (CVD) should no longer be based on BP level alone, but on absolute cardiovascular risk. While BP-lowering drug trea...
| Main Authors: | Ho, C., Sanders, S., Doust, J., Breslin, M., Reid, Christopher, Nelson, M. |
|---|---|
| Format: | Journal Article |
| Published: |
JMIR Publications
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/56939 |
Similar Items
SHOULD YOU LEAVE A LEGACY? POTENTIAL EFFECTS OF DELAYED BLOOD PRESSURE LOWERING PHARMACOTHERAPY IN INDIVIDUALS STRATIFIED BY ABSOLUTE CARDIOVASCULAR DISEASE RISK
by: Ho, C., et al.
Published: (2016)
by: Ho, C., et al.
Published: (2016)
Legacy effect of delayed blood pressure lowering drug treatment in middle-aged adults with mildly elevated blood pressure: systematic review and meta-analysis
by: Ho, C.L.B., et al.
Published: (2020)
by: Ho, C.L.B., et al.
Published: (2020)
Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: Post hoc analysis of the Australian National Blood Pressure Study
by: Ho, C., et al.
Published: (2018)
by: Ho, C., et al.
Published: (2018)
POST HOC ANALYSIS OF THE EFFECTIVENESS OF BLOOD PRESSURE-LOWERING DRUG TREATMENT BY LEVELS OF ABSOLUTE RISK IN THE ANBP STUDY
by: Ho, C., et al.
Published: (2017)
by: Ho, C., et al.
Published: (2017)
Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study
by: Ho, C., et al.
Published: (2018)
by: Ho, C., et al.
Published: (2018)
Absolute risk of cardiovascular disease events, and blood pressure- and lipid-lowering therapy in Australia
by: Dhaliwal, Satvinder, et al.
Published: (2017)
by: Dhaliwal, Satvinder, et al.
Published: (2017)
The effect of taking blood pressure lowering medication at night on cardiovascular disease risk. A systematic review
by: Ho, Chau L.B., et al.
Published: (2021)
by: Ho, Chau L.B., et al.
Published: (2021)
TEN-YEAR LEGACY EFFECTS OF BASELINE BLOOD PRESSURE TREATMENT NAIVETY IN THE SECOND AUSTRALIAN NATIONAL BLOOD PRESSURE STUDY.
by: Nelson, M., et al.
Published: (2015)
by: Nelson, M., et al.
Published: (2015)
Ten-year legacy effects of baseline blood pressure 'treatment naivety' in the Second Australian National Blood Pressure study
by: Nelson, M., et al.
Published: (2015)
by: Nelson, M., et al.
Published: (2015)
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
by: Yusuf, S., et al.
Published: (2016)
by: Yusuf, S., et al.
Published: (2016)
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
by: Lonn, E., et al.
Published: (2016)
by: Lonn, E., et al.
Published: (2016)
Blood-pressure and cholesterol lowering in persons without cardiovascular disease
by: Yusuf, Salim, et al.
Published: (2016)
by: Yusuf, Salim, et al.
Published: (2016)
Blood-pressure lowering in intermediate-risk persons without cardiovascular disease
by: Lonn, Eva M., et al.
Published: (2016)
by: Lonn, Eva M., et al.
Published: (2016)
Absolute stability of impulsive control systems with time delay
by: Liu, X., et al.
Published: (2005)
by: Liu, X., et al.
Published: (2005)
Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease
by: Ho, Chau Le Bao, et al.
Published: (2022)
by: Ho, Chau Le Bao, et al.
Published: (2022)
Fiction absolute and ethics: Tom Wolfe‘s back to blood
by: Jamshidian, Sahar, et al.
Published: (2014)
by: Jamshidian, Sahar, et al.
Published: (2014)
Kidney with lower pole simple cysts - is it an absolute contraindication for renal biopsy
by: Ng, Tze Ji, et al.
Published: (2020)
by: Ng, Tze Ji, et al.
Published: (2020)
The use of online debates in teaching pharmacotherapy
by: Charrois, Theresa, et al.
Published: (2012)
by: Charrois, Theresa, et al.
Published: (2012)
Pharmacotherapy for chronic hemorrhagic radiation proctitis
by: Alif Gul, Yunus Gul, et al.
Published: (2002)
by: Alif Gul, Yunus Gul, et al.
Published: (2002)
Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients
by: Chowdhury, E., et al.
Published: (2014)
by: Chowdhury, E., et al.
Published: (2014)
Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: The perindopril protection against recurrent stroke study trial
by: Czernichow, S., et al.
Published: (2010)
by: Czernichow, S., et al.
Published: (2010)
AbsolutelyBest ham to Pocatello, Idaho, USA: Arrival delay in customer’s order
by: Woodside, Arch
Published: (2016)
by: Woodside, Arch
Published: (2016)
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: Meta-analysis of randomized trials
by: Czernichow, S., et al.
Published: (2011)
by: Czernichow, S., et al.
Published: (2011)
Pharmacotherapy for amphetamine dependence: A systematic review
by: Lee, Nicole, et al.
Published: (2018)
by: Lee, Nicole, et al.
Published: (2018)
Online Debates to Enhance Critical Thinking in Pharmacotherapy
by: Charrois, Theresa, et al.
Published: (2013)
by: Charrois, Theresa, et al.
Published: (2013)
Pred/iction of cardiovascular events in subjects in the second australian national blood pressure study
by: Nelson, M., et al.
Published: (2010)
by: Nelson, M., et al.
Published: (2010)
Pharmacotherapy Outcomes And Cost Evaluation Of Paediatric Epilepsy In Penang Hospital
by: M. Salih, Muhannad R
Published: (2012)
by: M. Salih, Muhannad R
Published: (2012)
Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy
by: Tomek, M., et al.
Published: (2012)
by: Tomek, M., et al.
Published: (2012)
Inertia or inaction? blood pressure management and cardiovascular risk in diabetes
by: Owen, A., et al.
Published: (2009)
by: Owen, A., et al.
Published: (2009)
Stratified models of care
by: Foster, N., et al.
Published: (2013)
by: Foster, N., et al.
Published: (2013)
The Wittenoom Legacy
by: Musk, A., et al.
Published: (2018)
by: Musk, A., et al.
Published: (2018)
Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?
by: Prosser, H., et al.
Published: (2017)
by: Prosser, H., et al.
Published: (2017)
Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials.
by: Blood Pressure Lowering Treatment Trialists' Collaboration, et al.
Published: (2015)
by: Blood Pressure Lowering Treatment Trialists' Collaboration, et al.
Published: (2015)
Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary syndrome
by: Dagan, M., et al.
Published: (2022)
by: Dagan, M., et al.
Published: (2022)
Physical activity, alcohol and tobacco use and associated cardiovascular morbidity and mortality in the Second Australian National Blood Pressure study cohort
by: Nelson, M., et al.
Published: (2009)
by: Nelson, M., et al.
Published: (2009)
Pharmacotherapy of alzheimer’s disease: seeking clarity in a time of uncertainty
by: Ibrahim, Nurul Husna, et al.
Published: (2020)
by: Ibrahim, Nurul Husna, et al.
Published: (2020)
A review of psychotherapy as add-on treatment to pharmacotherapy for bipolar disorder
by: Tay, Lay Pheng, et al.
Published: (2014)
by: Tay, Lay Pheng, et al.
Published: (2014)
Studies On Side Effect Profile Of Treated Hypertensives On Selected Pharmacotherapy
by: Ismail, Marina
Published: (2001)
by: Ismail, Marina
Published: (2001)
Studies on side effect profile of treated hypertensives on selected pharmacotherapy
by: Ismail, Marina
Published: (2001)
by: Ismail, Marina
Published: (2001)
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
by: Yusuf, S., et al.
Published: (2016)
by: Yusuf, S., et al.
Published: (2016)
Similar Items
-
SHOULD YOU LEAVE A LEGACY? POTENTIAL EFFECTS OF DELAYED BLOOD PRESSURE LOWERING PHARMACOTHERAPY IN INDIVIDUALS STRATIFIED BY ABSOLUTE CARDIOVASCULAR DISEASE RISK
by: Ho, C., et al.
Published: (2016) -
Legacy effect of delayed blood pressure lowering drug treatment in middle-aged adults with mildly elevated blood pressure: systematic review and meta-analysis
by: Ho, C.L.B., et al.
Published: (2020) -
Effectiveness of blood pressure-lowering drug treatment by levels of absolute risk: Post hoc analysis of the Australian National Blood Pressure Study
by: Ho, C., et al.
Published: (2018) -
POST HOC ANALYSIS OF THE EFFECTIVENESS OF BLOOD PRESSURE-LOWERING DRUG TREATMENT BY LEVELS OF ABSOLUTE RISK IN THE ANBP STUDY
by: Ho, C., et al.
Published: (2017) -
Short- and long-term association of lipid-lowering drug treatment and cardiovascular disease by estimated absolute risk in the Second Australian National Blood Pressure study
by: Ho, C., et al.
Published: (2018)